Sobi

FDA stop sign

FDA snubs Sobi’s gout drug over manufacturing issues

The FDA cited deficiencies at a contract manufacturing facility and is requiring additional data related to manufacturing control strategy.

Angus Liu Jun 29, 2026 11:04am

Novo Nordisk Wegovy Live Lighter ad

FDA untitled letters target drug ads from Novo, argenx, Sobi

Feb 10, 2026 11:42am

A photo finish at a horse race with both horses crossing the finish line

Sobi tops Roche in rare disease patients' reputation rankings

Sep 23, 2025 12:33pm

empaveli

Sobi places $300M bet on Empaveli in partnership with Apellis

Jul 1, 2025 11:28am

Blue race track

Novartis, Apellis roll out rival datasets in rare kidney disease

Oct 28, 2024 10:03am

winnter trophy star

Watch out, Novartis. Apellis scores major win in kidney diseases

Aug 8, 2024 2:28pm